Hypophosphatasia-aetiology, nosology, pathogenesis, diagnosis and treatment

Nature Reviews Endocrinology

Volumn 12, Issue 4, 2016, Pages 233-246

  Whyte, Michael P ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE ISOENZYME; MINERAL; PHOSPHOETHANOLAMINE; PYRIDOXAL 5 PHOSPHATE; PYROPHOSPHATE; TISSUE NONSPECIFIC ISOENZYME OF ALKALINE PHOSPHATASE; UNCLASSIFIED DRUG; ALPL PROTEIN, HUMAN;

ARTHROPATHY; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BENIGN PRENATAL HYPOPHOSPHATASIA; BIOCHEMICAL ANALYSIS; CHILDHOOD DISEASE; CIRCULATION; DISEASE CLASSIFICATION; EPIGENETICS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYDROLYSIS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOPHOSPHATASIA; LOSS OF FUNCTION MUTATION; MINERALIZATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; ODONTOHYPOPHOSPHATASIA; OSTEOMALACIA; PATHOGENESIS; PERINATAL HYPOPHOSPHATASIA; PERIODONTAL DISEASE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; PSEUDOHYPOPHOSPHATASIA; REVIEW; RICKETS; VITAMIN BLOOD LEVEL; BONE; BONE MARROW TRANSPLANTATION; ENZYME REPLACEMENT; EPILEPSY; GENE THERAPY; GENETICS; MUTATION; PATHOPHYSIOLOGY; RADIOGRAPHY;

ALKALINE PHOSPHATASE; BONE AND BONES; BONE MARROW TRANSPLANTATION; ENZYME REPLACEMENT THERAPY; EPILEPSY; GENETIC THERAPY; HUMANS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOPHOSPHATASIA; MUTATION;

EID: 84961216480     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.14     Document Type: Review

References (142)

1. Rathbun, J. C. Hypophosphatasia: a new developmental anomaly. Am. J. Dis. Child. 75, 822-831 (1948
2. Fraser, D. Hypophosphatasia. Am. J. Med. 22, 730-746 (1957
3. Sobel, E. H., Clark, L. C. Jr, Fox, R. P. & Robinow, M. Rickets, deficiency of alkaline phosphatase activity and premature loss of teeth in childhood. Pediatrics 11, 309-322 (1953
4. Online mendelian inheritance in man®. OMIM® [online], http: //omim.org/ (2015
5. Robison, R. The possible significance of hexosephosphoric esters in ossification. J. Biol. Chem. 17, 286-293 (1923
6. McComb, R. B., Bowers, G. N. Jr & Posen, S. Alkaline Phosphatase (Plenum Press, 1979
7. Millan, J. L. Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology (Wiley-VCH, 2006
8. Whyte, M. P. in Genetics of Bone Biology and Skeletal Disease 1st edn Ch. 22 (eds Thakker, R. V., et al.) 337-360 (Academic Press, 2013
9. Weiss, M. J., et al. Structure of the human liver/bone/ kidney alkaline phosphatase gene. J. Biol. Chem. 263, 12002-12010 (1988
10. Kim, E. E. & Wyckoff, H. W. Reaction mechanism of alkaline phosphatase based on crystal structures: two-metal ion catalysis. J. Mol. Biol. 218, 449-464 (1991
11. Henthorn, P. S. & Whyte, M. P. Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia. Clin. Chem. 38, 2501-2505 (1992
12. Nosjean, O., Koyama, I., Goseki, M., Roux, B. & Komoda, T. Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects. Biochem. J. 321, 297-303 (1997
13. Kiledjian, M. & Kadesch, T. Analysis of the human liver/bone/kidney alkaline phosphatase promoter in vivo and in vitro. Nucleic Acids Res. 18, 957-961 (1990
14. Xu, Y., Cruz, T. F. & Pritzker, K. P. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals. J. Rheumatol. 18, 1606-1610 (1991
15. Farley, J. R. Phosphate regulates the stability of skeletal alkaline phosphatase activity in human osteosarcoma (SaOS 2) cells without equivalent effects on the level of skeletal alkaline phosphatase immunoreactive protein. Calcif. Tissue Int. 57, 371-378 (1995
16. Hawrylak, K & Stinson, R. A. Tetrameric alkaline phosphatase from human liver is converted to dimers by phosphatidylinositol phospholipase C. FEBS Lett. 212, 289-291 (1987
17. Young, G. P., Rose, I. S., Cropper, S., Seetharam, S. & Alpers, D. H. Hepatic clearance of rat plasma intestinal alkaline phosphatase. Am. J. Physiol. 247, G419-G426 (1984
18. Millan, J. L., Whyte, M. P., Avioli, L. V. & Fishman, W. H. Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred. Clin. Chem. 26, 840-845 (1980
19. Gorodischer, R., Davidson, R. G., Mosovich, L. L. & Yaffe, S. J. Hypophosphatasia: a developmental anomaly of alkaline phosphatase?. Pediatr. Res. 10, 650-656 (1976
20. Vanneuville, F. J. & Leroy, J. G. Hypophosphatasia: biochemical diagnosis in post-mortem organs, plasma and diploid skin fibroblasts [proceedings]. Arch. Int. Physiol. Biochim. 87, 854-855 (1979
21. Mueller, H. D., Stinson, R. A., Mohyuddin, F. & Milne, J. K. Isoenzymes of alkaline phosphatase in infantile hypophosphatasia. J. Lab. Clin. Med. 102, 24-30 (1983
22. Whyte, M. P. in Principles of Bone Biology 3rd edn (eds Bilezikian, J. P., et al.) 1573-1598 (Academic Press, 2008
23. Weiss, M. J., et al. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc. Natl Acad. Sci. USA 85, 7666-7669 (1988
24. Henthorn, P. S., Raducha, M., Fedde, K. N., Lafferty, M. A. & Whyte, M. P. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc. Natl Acad. Sci. USA 89, 9924-9928 (1992
25. Mornet, E. Tissue nonspecific alkaline phosphatase gene mutations database. SESEP [online], http: // www.sesep.uvsq.fr/03-hypo-mutations.php (2015
26. Whyte, M. P., et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75, 229-239 (2015
27. Henthorn, P., Ferrero, A., Fedde, K., Coburn, S. P. & Whyte, M. P. Hypophosphatasia mutation D361V exhibits dominant effects both in vivo and in vitro [abstract]. Am. J. Hum. Genet. 59, A-199 (1996
28. Ozono, K., et al. Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia. J. Clin. Endocrinol. Metab. 81, 4458-4461 (1996
29. Greenberg, C. R., et al. A homoallelic Gly317?Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian Mennonites. Genomics 17, 215-217 (1993
30. Whyte, M. P., Essmyer, K., Geimer, M. & Mumm, S. Homozygosity for TNSALP mutation 1348C>T (Arg 433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J. Pediatr. 148, 753-758 (2006
31. Mumm, S., et al. Hypophosphatasia: the c.1133A>T, D378V transversion is the most common American TNSALP mutation [abstract]. J. Bone Miner. Res. 21, S115 (2006
32. Mornet, E., Yvard, A., Taillandier, A., Fauvert, D. & Simon-Bouy, B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann. Hum. Genet. 75, 439-445 (2011
33. Ozono, K. & Michigami, T. Hypophosphatasia now draws more attention of both clinicians and researchers: a commentary on prevalence of c. 1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasias in Japanese and effects of the mutation on heterozygous carriers. J. Hum. Genet. 56, 174-175 (2011
34. Wenkert, D., et al. Hypophosphatasia: non-lethal disease despite skeletal presentation in utero (17 new cases and literature review). J. Bone Miner. Res. 26, 2389-2398 (2011
35. Scriver, C. R. & Cameron, D. Pseudohypophosphatasia. N. Engl. J. Med. 281, 604-606 (2011
36. Madson, K. L., Gill, S. S., Mumm, S. & Whyte, M. P. Pseudohypophosphatasia: mutation identification and 46 year follow up of the original patient [abstract]. J. Bone Miner. Res. 30, S190 (2015
37. Whyte, M. P., Teitelbaum, S. L., Murphy, W. A., Bergfeld, M. A. & Avioli, L. V. Adult hypophosphatasia: clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 58, 329-347 (1979
38. Sutton, R. A., Mumm, S., Coburn, S. P., Ericson, K. L. & Whyte, M. P. 'Atypical femoral fractures' during bisphosphonate exposure in adult hypophosphatasia. J. Bone Miner. Res. 27, 987-994 (2012
39. Lundgren, T., Westphal, O., Bolme, P., Modeer, T. & Noren, J. G. Retrospective study of children with hypophosphatasia with reference to dental changes. Scand. J. Dent. Res. 99, 357-364 (1991
40. Khandwala, H. M., Mumm, S. & Whyte, M. P. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr. Pract. 12, 676-681 (2006
41. Coe, J. D., Murphy, W. A. & Whyte, M. P. Management of femoral fractures and pseudofractures in adult hypophosphatasia. J. Bone Joint Surg. Am. 68, 981-990 (1986
42. Whyte, M. P. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J. Bone Miner. Res. 24, 1132-1134 (2009
43. Whyte, M. P., Mumm, S. & Deal, C. Adult hypophosphatasia treated with teriparatide. J. Clin. Endocrinol. Metab. 92, 1203-1208 (2007
44. Chuck, A. J., Pattrick, M. G., Hamilton, E., Wilson, R. & Doherty, M. Crystal deposition in hypophosphatasia: a reappraisal. Ann. Rheum. Dis. 48, 571-576 (1989
45. Whyte, M. P., Murphy, W. A. & Fallon, M. D. Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred. Am. J. Med. 72, 631-641 (1982
46. Gua'abens, N., et al. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-Aged sisters. J. Bone Miner. Res. 29, 929-934 (2014
47. Lassere, M. N. & Jones, J. G. Recurrent calcific periarthritis, erosive osteoarthritis and hypophosphatasia: a family study. J. Rheumatol. 17, 1244-1248 (1990
48. Weinstein, R. S. & Whyte, M. P. Fifty-year follow up of hypophosphatasia. Arch. Int. Med. 141, 1720-1721 (1981
49. Fallon, M. D., et al. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 63, 12-24 (1984
50. Collmann, H., Mornet, E., Gattenlohner, S., Beck, C. & Girschick, H. Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv. Syst. 25, 217-223 (2009
51. Seshia, S. S., Derbyshire, G., Haworth, J. C. & Hoogstraten, J. Myopathy with hypophosphatasia. Arch. Dis. Child. 65, 130-131 (1990
52. Whyte, M. P., et al. Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J. Bone Miner. Res. 24, 1493-1505 (2009
53. Kozlowski, K., et al. Hypophosphatasia. Review of 24 cases. Pediatr. Radiol. 5, 103-117 (1976
54. Whyte, M. P., Wenkert, D., McAlister, W. H., Mack, K. E. & Zhang, F. Hypophosphatasia: natural history study of 101 affected children followed at one research center [abstract]. J. Bone Miner. Res. 30, S189 (2015
55. Lepe, X., Rothwell, B. R., Banich, S. & Page, R. C. Absence of adult dental anomalies in familial hypophosphatasia. J. Periodontal Res. 32, 375-380 (1997
56. Whyte, M. P., et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N. Engl. J. Med. 366, 904-913 (2012
57. Whyte, M. P., Valdes, R. Jr, Ryan, L. M. & McAlister, W. H. Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. J. Pediatr. 101, 379-386 (1982
58. Sty, J. R., Boedecker, R. A. & Babbitt, D. P. Skull scintigraphy in infantile hypophosphatasia. J. Nucl. Med. 20, 305-306 (1979
59. Baumgartner-Sigl, S., et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p. T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40, 1655-1661 (2007
60. Whyte, M. P., et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J. Clin. Endocrinol. Metab. 101, 334-342 (2016
61. Taillard, F., et al. L'hypophosphatasie affection polymorphe De fréquence peut-e?tre sous estimée. Infantile 91, 559-576 (in French) (1984
62. Shohat, M., Rimoin, D. L., Gruber, H. E. & Lachman, R. S. Perinatal lethal hypophosphatasia; clinical, radiologic and morphologic findings. Pediatr. Radiol. 21, 421-427 (1991
63. Silver, M. M., Vilos, G. A. & Milne, K. J. Pulmonary hypoplasia in neonatal hypophosphatasia. Pediatr. Pathol. 8, 483-493 (1988
64. Cole, D. E., et al. Increased serum pyridoxal 5? phosphate in pseudohypophosphatasia. N. Engl. J. Med. 314, 992-993 (1986
65. Heaton, B. W. & McClendon, J. L. Childhood pseudohypophosphatasia. Clinical and laboratory study of two cases. Tex. Dent. J. 103, 4-8 (1986
66. Rubecz, I., et al. Hypophosphatasia: screening and family investigation. Clin. Genet. 6, 155-159 (1974
67. Robison, R The Significance of Phosphoteric Esters in Metabolism (New York Universty Press, 1932
68. Murshed, M., Harmey, D., Millan, J. L., McKee, M. D. & Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19, 1093-1104 (2005
69. Anderson, H. C., Hsu, H. H., Morris, D. C., Fedde, K. N. & Whyte, M. P. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am. J. Pathol. 151, 1555-1561 (1997
70. Ornoy, A., Adomian, G. E. & Rimoin, D. L. Histologic and ultrastructural studies on the mineralization process in hypophosphatasia. Am. J. Med. Genet. 22, 743-758 (1985
71. Fraser, D., Yendt, E. R. & Christie, F. H. Metabolic abnormalities in hypophosphatasia. Lancet 268, 286 (1955
72. Fleisch, H., Russell, R. G. & Straumann, F. Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212, 901-903 (1966
73. Russell, R. G., Bisaz, S., Donath, A., Morgan, D. B. & Fleisch, H. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J. Clin. Invest. 50, 961-969 (1971
74. Moss, D. W., Eaton, R. H., Smith, J. K. & Whitby, L. G. Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem. J. 102, 53-57 (1967
75. Chapple, I. L. Hypophosphatasia: dental aspects and mode of inheritance. J. Clin. Periodontol. 20, 615-622 (1993
76. Currarino, G., Neuhauser, E. B., Reyersbach, G. C. & Sobel, E. H. Hypophosphatasia. Am. J. Roentgenol. Radium Ther. Nucl. Med. 78, 392-419 (1957
77. Whyte, M. P. & Seino, Y. Circulating vitamin D metabolite levels in hypophosphatasia. J. Clin. Endocrinol. Metab. 55, 178-180 (1982
78. Opshaug, O., Maurseth, K., Howlid, H., Aksnes, L. & Aarskog, D. Vitamin D metabolism in hypophosphatasia. Acta Paediatr. Scand. 71, 517-521 (1982
79. Whyte, M. P. & Rettinger, S. D. Hyperphosphatemia due to enhanced renal reclamation of phosphate in hypophosphatasia [abstract]. J. Bone Miner. Res. 2 (Suppl. 1) 399 (1987
80. Otero, J. E., et al. Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy. J. Bone Miner. Res. 28, 419-430 (2013
81. Rutsch, F., et al. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ. Cardiovasc. Genet. 1, 133-140 (2008
82. McCance, R. A., Morrison, A. B. & Dent, C. E. The excretion of phosphoethanolamine and hypophosphatasia. Lancet 268, 131 (1955
83. Russell, R. G. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet 10, 461-464 (1965
84. Whyte, M. P., Mahuren, J. D., Vrabel, L. A. & Coburn, S. P. Markedly increased circulating pyridoxal 5? phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J. Clin. Invest. 76, 752-756 (1985
85. Coburn, S. P. & Whyte, M. P. in Clinical and Physiological Applications of Vitamin B-6 (eds Leklem, J. E. & Reynolds, R. D.) 65-93 (AR Liss, 1988
86. Fedde, K. N. & Whyte, M. P. Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal 5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am. J. Hum. Genet. 47, 767-775 (1990
87. Fedde, K. N., Lane, C. C. & Whyte, M. P. Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS 2) cells. Arch. Biochem. Biophys. 264, 400-409 (1988
88. Rasmussen, K. Phosphorylethanolamine and hypophosphatasia. Dan. Med. Bull. 15, 1-112 (1968
89. Gron, I. H. Mammalian O phosphorylethanolamine phospho-lyase activity and its inhibition. Scand. J. Clin. Lab. Invest. 38, 107-112 (1978
90. Whyte, M. P., et al. Perinatal hypophosphaasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal 5? phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J. Clin. Invest. 81, 1234-1239 (1988
91. Caswell, A. M., Whyte, M. P. & Russell, R. G. Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects. Crit. Rev. Clin. Lab. Sci. 28, 175-232 (1991
92. Moore, C. A., Ward, J. C., Rivas, M. L., Magill, H. L. & Whyte, M. P. Infantile hypophosphatasia: autosomal recessive transmission to two related sibships. Am. J. Med. Genet. 36, 15-22 (1990
93. Macfarlane, J. D., Kroon, H. M. & Van Der Harten, J. J. Phenotypically dissimilar hypophosphatasia in two sibships. Am. J. Med. Genet. 42, 117-121 (1992
94. Yadav, M. C., et al. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J. Bone Miner. Res. 26, 286-297 (2011
95. Fedde, K. N., et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14, 2015-2026 (1991
96. Millan, J. L. & Whyte, M. P. Alkaline phosphatase and hypophosphatasia. Calcif. Tissue Int. http: //dx.doi.org/ 10.1007/s00223-015-0079-1 (2015
97. Hough, T. A., et al. Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2. J. Bone Miner. Res. 22, 1397-1407 (2007
98. Foster, B. L., et al. Periodontal defects in the A116T knock in mouse model of odontohypophosphatasia. J. Dent. Res. 94, 706-714 (2015
99. Kleinman, G., Uri, M., Hull, S. & Keene, C. Perinatal ultrasound casebook. Antenatal findings in congenital hypophosphatasia. J. Perinatol. 11, 282-284 (1991
100. Whyte, M. P. in Pediatric Bone: Biology and Diseases 3rd edn (eds Glorieux, F. H., et al.) 771-794 (Academic Press, 2012
101. McKiernan, F. E., Berg, R. L. & Fuehrer, J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J. Bone Miner. Res. 29, 1651-1660 (2014
102. Royce, P. M., et al. Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia. Eur. J. Pediatr. 147, 626-631 (1988
103. El Gharbawy, A. H., et al. Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C terminal region of RUNX2. Am. J. Med. Genet. A 152A, 169-174 (2010
104. Licata, A. A., Radfar, N., Bartter, F. C. & Bou, E. The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia. Am. J. Med. 64, 133-138 (1978
105. Chodirker, B. N., Coburn, S. P., Seargeant, L. E., Whyte, M. P. & Greenberg, C. R. Increased plasma pyridoxal 5? phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia. J. Inherit. Metab. Dis. 13, 891-896 (1990
106. Macfarlane, J. D., Poorthuis, B. J., Mulivor, R. A. & Caswell, A. M. Raised urinary excretion of inorganic pyrophosphate in asymptomatic members of a hypophosphatasia kindred. Clin. Chim. Acta. 202, 141-148 (1991
107. Rockman-Greenberg, C., et al. Asfotase alfa: Sustained efficacy and tolerability in children with hypophosphatasia treated for 5 years. J. Bone Miner. Res. 30 (Suppl. 1), http: //www.asbmr.org/education/ AbstractDetail?aid=25f0b55b-32f2-4df7-b81c- 2de3107bc114 (2015
108. Zhang, F., Whyte, M. P. & Wenkert, D. Improving dual-energy X ray absorptiometry (DXA) interpretation: a simple equation for height correction for pre-teenage children. J. Clin. Densitom. 15, 267-274 (2012
109. el Labban, N. G., Lee, K. W. & Rule, D. Permanent teeth in hypophosphatasia: light and electron microscopic study. J. Oral Pathol. Med. 20, 352-360 (1991
110. Watanabe, A., et al. Perinatal hypophosphatasia caused by uniparental isodisomy. Bone 60, 93-97 (2014
111. Rudd, N. L., Miskin, M., Hoar, D. I., Benzie, R. & Doran, T. A. Prenatal diagnosis of hypophosphatasia. N. Engl. J. Med. 295, 146-148 (1976
112. Mulivor, R. A., Mennuti, M., Zackai, E. H. & Harris, H. Prenatal diagnosis of hypophosphatasia; genetic, biochemical, and clinical studies. Am. J. Hum. Genet. 30, 271-282 (1978
113. Brock, D. J. & Barron, L. First-trimester prenatal diagnosis of hypophosphatasia: experience with 16 cases. Prenat. Diagn. 11, 387-391 (1991
114. Hausser, C., Habib, R. & Poitras, P. Hypophosphatasia: complete absence of the fetal skeleton. Union Med. Can. 113, 978-979 (1984
115. Henthorn, P. S. & Whyte, M. P. Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations. Prenat. Diagn. 15, 1001-1006 (1995
116. Orimo, H., et al. First-trimester prenatal molecular diagnosis of infantile hypophosphatasia in a Japanese family. Prenat. Diagn. 16, 559-563 (1996
117. Leung, E. C., et al. Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis. JIMD Rep. 11, 73-78 (2013
118. Whyte, M. P., et al. Marrow cell transplantation for infantile hypophosphatasia. J. Bone Miner. Res. 18, 624-636 (2003
119. Cahill, R. A., et al. Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J. Clin. Endocrinol. Metab. 92, 2923-2930 (2007
120. Ish-shalom, S., et al. A follow up of hypophosphatasia from infancy to adulthood [abstract]. Presented at the annual meeting of the Pediatric Working Group, American Society for Bone and Mineral Research (1986
121. Rodriguez, E., et al. Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy. Pediatr. Pulmonol. 47, 917-922 (2012
122. Barcia, J. P., Strife, C. F., & Langman, C. B. Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J. Pediatr. 130, 825-828 (1997
123. Girschick, H. J., et al. Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J. Rare Dis. 1, 24 (2006
124. Fraser, D. & Laidlaw, J. C. Treatment of hypophosphatasia with cortisone. Lancet 1, 553 (1956
125. Whyte, M. P., et al. Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J. Pediatr. 105, 926-933 (1984
126. Whyte, M. P., et al. Failure of hyperphosphatasemia by intravenous infusion of purified placental alkaline phosphatase (ALP) to correct severe hypophosphatasia: evidence against a role for circulating ALP in skeletal mineralization [abstract]. J. Bone Miner. Res. 7, S155 (1992
127. Camacho, P. M., Painter, S. & Kadanoff, R. Treatment of adult hypophosphatasia with teriparatide. Endocr. Pract. 14, 204-208 (2008
128. Schalin-Jantti, C., Mornet, E., Lamminen, A. & Valimaki, M. J. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J. Clin. Endocrinol. Metab. 95, 5174-5179 (2010
129. McKee, M., et al. Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J. Dent. Res. 90, 470-476 (2011
130. Millán, J. L., et al. Enzyme replacement therapy for murine hypophosphatasia. J. Bone Miner. Res. 23, 777-787 (2008
131. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT00739505?term=NCT00739505&rank=1 (2014
132. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT00744042?term=NCT00744042&rank=1 (2015
133. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01205152?term=NCT01205152&rank=1 (2015
134. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT00952484?term=NCT00952484&rank=1 (2014
135. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01203826?term=NCT01203826&rank=1 (2015
136. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01163149?term=NCT01163149&rank=1 (2015
137. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01176266?term=NCT01176266&rank=1 (2015
138. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT02496689?term=NCT02496689&rank=1 (2015
139. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT02531867?term=NCT02531867&rank=1 (2015
140. US National Library of Science. Clinical Trials.gov [online], https://clinicaltrials.gov/ct2/show/NCT02456038?term=NCT02456038&rank=1 (2015
141. Gasque, K. C., et al. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone 72, 137-147 (2015
142. Yamamoto, S., et al. Prolonged survival and phenotypic correction of Akp2-/- hypophosphatasia mice by lentiviral gene therapy. J. Bone Miner. Res. 26, 135-142 (2011